Opaleye Management’s Biodesix BDSX Stock Holding History

Opaleye Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.06M	Sell	180,000 -58,047	-24%	-$860K	0.37%	40
2026 Q1	$3.45M	Buy	+238,047	New	+$2.95M	0.45%	38
2025 Q2	–	Sell	-161,250	Closed	-$2.02M	–	43
2025 Q1	$2.02M	Sell	161,250 -12,000	-7%	-$230K	0.45%	32
2024 Q4	$5.3M	Sell	173,250 -17,500	-9%	-$515K	0.93%	23
2024 Q3	$6.97M	Sell	190,750 -10,250	-5%	-$353K	1.16%	18
2024 Q2	$6.15M	Buy	201,000 +174,267	+652%	+$4.98M	1.41%	23
2024 Q1	$765K	Buy	26,733 +1,908	+8%	+$65.3K	0.17%	49
2023 Q4	$3.61M	Buy	24,825 +2,046	+9%	+$64.2K	0.96%	26
2023 Q3	$3.04M	Buy	+22,779	New	+$632K	0.99%	29

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Opaleye Management's BDSX Position: Q2 2026 in Review

Opaleye Management reduced its Biodesix (BDSX) stake by 24% in Q2 2026, selling an estimated $860K and leaving 180,000 shares worth $4.06M. The position accounts for 0.37% of the portfolio, ranked #40.

Opaleye Management first reported a position in BDSX in Q3 2023 and has held it in 9 quarters since. The position peaked at $6.97M in Q3 2024. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Opaleye Management held 180,000 shares of Biodesix worth $4.06M as of Q2 2026.
Opaleye Management sold 58,047 Biodesix shares in Q2 2026, an estimated $860K.
Biodesix made up 0.37% of Opaleye Management's portfolio in Q2 2026, its #40 holding.
Opaleye Management first reported a position in Biodesix in Q3 2023 and has held it in 9 quarters since.
Opaleye Management's Biodesix position peaked at $6.97M in Q3 2024.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Opaleye Management's 13F filing for Q2 2026, filed 14 Aug 2026.